Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB26FY18U
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,498
Award facts
- Contract value 100% obligated
- $12,497.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,497.58 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Nexplanon 68 mg implants. The delivery order, issued on October 22, 2025, with an ultimate completion date of November 13, 2025, contains no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group serves as a critical pharmaceutical supplier within the Defense Department's medical supply chain and has established a strong track record of performance across multiple therapeutic categories and product lines.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The underlying indefinite delivery contract, awarded on November 13, 2025, carries a $499.999 billion ceiling value and extends through December 31, 2036, positioning the contractor as one of multiple regional prime vendor suppliers under the broader $30.3 billion PPV-G GEN V acquisition strategy. This framework authorizes DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products and medical consumables to support recurring medical supply needs of military healthcare facilities worldwide, enabling DMS Pharmaceutical Group to serve as a foundational supplier for Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB26FY18U?
SPE2DB26FY18U was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DB26FY18U worth?
The government has obligated $12,498 on SPE2DB26FY18U.
Is contract SPE2DB26FY18U an order under another contract?
Yes. SPE2DB26FY18U is a delivery order under SPE2DB22D9362, an indefinite delivery contract.
Was contract SPE2DB26FY18U competed?
The extent of competition for SPE2DB26FY18U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award